What is the treatment for nonspecific colitis (inflammatory bowel disease)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Nonspecific Colitis Treatment

The primary approach for treating nonspecific colitis, also known as inflammatory bowel disease (IBD), is to manage symptoms and reduce inflammation.

  • A common initial treatment is with mesalamine, an anti-inflammatory medication, at a dose of 800-1600 mg orally three times a day for 6-8 weeks 1.
  • Patients may also be advised to follow a bland diet, stay hydrated, and avoid spicy or high-fiber foods that can exacerbate symptoms.
  • In some cases, corticosteroids like prednisone may be prescribed for short-term use to reduce inflammation, typically at a dose of 20-40 mg orally once a day for 2-4 weeks, with a gradual taper 1.
  • It's also important to rule out other causes of colitis, such as infectious colitis, and to consider probiotics or fiber supplements for long-term management and prevention of flare-ups.
  • For patients who do not respond to initial treatment, infliximab or vedolizumab may be considered as alternative options 1.
  • In severe cases, hospitalization may be necessary to manage symptoms and prevent complications, with treatment options including intravenous steroids and other immunosuppressive medications 1.

From the Research

Treatment for Nonspecific Colitis

The treatment for nonspecific colitis, also known as inflammatory bowel disease, can vary depending on the severity and extent of the disease.

  • For mild-to-moderate cases, treatment options include:
    • Aminosalicylates, such as mesalamine 2, 3, 4
    • Topical corticosteroids 2
    • Oral corticosteroids for unresponsive cases 2
  • For moderate-to-severe cases, treatment options include:
    • Oral or intravenous corticosteroids in the short-term 2
    • Biologic agents, such as tumor necrosis factor-α inhibitors, as initial therapy or in transition from steroids 2, 3
    • Thiopurines, such as azathioprine, as bridging therapy 2, 3, 4
  • For severe or fulminant cases, treatment options include:
    • Colectomy, which may be a life-saving procedure 2, 3
    • Early surgical referral is crucial for severe or refractory cases 2
  • It's also important to note that patients with nonspecific colitis should continue their follow-up by a specialized ward, as some cases may be underdiagnosed 5

Treatment for Specific Types of Colitis

  • For microscopic colitis, treatment options include:
    • Budesonide oral or enema, which is the gold standard 6
    • Bile acid sequestrants, such as cholestyramine, colesevelam, and colestipol 6
    • Biologics, such as infliximab, adalimumab, and vedolizumab 6
  • For ulcerative colitis, treatment options include:
    • Mesalamine, which remains the standard treatment for uncomplicated cases 3
    • Glucocorticoids, which are highly effective in the acute treatment but should only be used over the short term due to their marked side effects 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current approaches to the management of new-onset ulcerative colitis.

Clinical and experimental gastroenterology, 2014

Research

Ulcerative Colitis-Diagnostic and Therapeutic Algorithms.

Deutsches Arzteblatt international, 2020

Research

Nonbiological therapeutic management of ulcerative colitis.

Expert opinion on pharmacotherapy, 2018

Research

P073 Diagnostic Outcome of Patients With Non-Specific Colitis.

The American journal of gastroenterology, 2021

Related Questions

What is the initial treatment for nonspecific acute colitis?
What is the best management plan for a patient with severe acute ulcerative colitis (UC) and toxic colitis, presenting with bloody diarrhea, abdominal pain, tenderness, fever, anemia, leukocytosis, hypoalbuminemia, elevated erythrocyte sedimentation rate (ESR), and elevated C-reactive protein (CRP)?
What is the initial treatment for acute colitis?
What is the management for a patient with severe fulminant Ulcerative Colitis (UC) and toxic megacolon that has not improved with medical treatment?
What is the best management plan for a patient with severe acute ulcerative colitis (UC) and toxic colitis, presenting with bloody diarrhea, abdominal pain, tenderness, fever, anemia, leukocytosis, hypoalbuminemia, and elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)?
What is the assessment and plan for hematology clearance for neurosurgery in a patient with a history of C1 fracture 8 months ago and a 4 cm Pulmonary Embolism (PE) exactly 3 months ago, whose 83-year-old mother has frailty, limited mobility, and foot drop?
Alternatives for broad-spectrum coverage in penicillin allergy?
What are the treatment options for ulcerative colitis (UC) when no specific treatment is effective?
What is the assessment and plan for hematology clearance for neurosurgery in an 83-year-old patient with a history of C1 (cervical spine) fracture 8 months ago and a 4 cm Pulmonary Embolism (PE) exactly 3 months ago, presenting with frailty, limited mobility, progressive weakness, and foot drop?
What are the next steps in recommendations for dysphagia in an elderly female with presbyesophagus?
Does sublingual administration of Opamox (Amoxicillin) enhance its onset of action?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.